CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
- PMID: 11408019
- DOI: 10.1016/s0009-9120(01)00217-x
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
Abstract
Objectives: To determine the cytotoxicity of valproic acid (VPA) and its metabolite, 4-ene-valproic acid (4-ene-VPA) in human hepatoblastoma cells (Hep G2), and to study the modulatory effect of cytochrome P450 2E1 induction in this model.
Methods: Cells were exposed to VPA or 4-ene-VPA in the presence of either ethanol (EtOH), or EtOH combined with disulphiram (DS). Some cells were exposed to alpha-fluoro-VPA or to alpha-fluoro-4-ene-VPA in the absence of CYP2E1 inducers. Apoptosis and necrosis were measured by analyzing 6000 cells per sample using transmission electron microscopy, while cytokine release and apoptosis were quantitated by ELISA.
Results: VPA + EtOH increased VPA cytotoxicity. 4-ene-VPA + EtOH significantly increased toxicity, while DS + EtOH significantly reduced this toxicity. Alpha-fluorinated analogues reduced cytotoxicity compared to the corresponding VPA compounds. Neither VPA nor alpha-fluorinated VPA increased the release of IL-6 or TNF-alpha in media. A significant increase in the release of TNF-alpha was observed in cells exposed to 4-ene-VPA that further increased with EtOH exposure.
Conclusions: Cells exposed to 4-ene-VPA experience greater cytotoxicity than those treated with VPA. Cytochrome P450 2E1 inducers enhance toxicity in VPA-exposed cells, while alpha-fluorination of VPA diminishes cytotoxicity by directly interfering with the beta-oxidation of the 4-ene-VPA metabolite.
Similar articles
-
Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.Chem Res Toxicol. 1995 Jul-Aug;8(5):671-82. doi: 10.1021/tx00047a006. Chem Res Toxicol. 1995. PMID: 7548749
-
Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes.Toxicology. 1996 Aug 1;112(1):69-85. doi: 10.1016/0300-483x(96)03352-5. Toxicology. 1996. PMID: 8792850
-
Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity.Clin Biochem. 1999 Oct;32(7):519-36. doi: 10.1016/s0009-9120(99)00052-1. Clin Biochem. 1999. PMID: 10614715
-
Valproic acid derivatives signal for apoptosis and repair in vitro.Clin Biochem. 2013 Oct;46(15):1532-7. doi: 10.1016/j.clinbiochem.2013.07.003. Epub 2013 Jul 15. Clin Biochem. 2013. PMID: 23868021
-
Children versus adults: pharmacokinetic and adverse-effect differences.Epilepsia. 2002;43 Suppl 3:53-9. doi: 10.1046/j.1528-1157.43.s.3.5.x. Epilepsia. 2002. PMID: 12060006 Review.
Cited by
-
Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes.Arch Toxicol. 2024 Jun;98(6):1581-1628. doi: 10.1007/s00204-024-03710-9. Epub 2024 Mar 23. Arch Toxicol. 2024. PMID: 38520539 Review.
-
Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods.Int J Mol Sci. 2022 Mar 18;23(6):3315. doi: 10.3390/ijms23063315. Int J Mol Sci. 2022. PMID: 35328737 Free PMC article. Review.
-
Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.Molecules. 2021 Dec 24;27(1):104. doi: 10.3390/molecules27010104. Molecules. 2021. PMID: 35011339 Free PMC article. Review.
-
Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital.J Clin Med. 2021 Mar 10;10(6):1153. doi: 10.3390/jcm10061153. J Clin Med. 2021. PMID: 33801850 Free PMC article.
-
Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study.Drugs Real World Outcomes. 2016 Mar;3(1):7-12. doi: 10.1007/s40801-015-0053-2. Drugs Real World Outcomes. 2016. PMID: 27747801 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources